| Stem definition | Drug id | CAS RN |
|---|---|---|
| 516 | 2622-30-2 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA | WYETH AYERST |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| CHEBI has role | CHEBI:37930 | phenothiazine antipsychotic drugs |
| CHEBI has role | CHEBI:48561 | dopaminergic antagonists |
| CHEBI has role | CHEBI:50919 | antiemetico |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Chronic schizophrenia | indication | 83746006 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 8.21 | Basic |
| pKa2 | 4.21 | Basic |
| pKa3 | 1.58 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| D(2) dopamine receptor | GPCR | ANTAGONIST | DRUGBANK | CHEMBL | |||||
| 5-hydroxytryptamine receptor 2A | GPCR | ANTAGONIST | CHEMBL | CHEMBL |
| ID | Source |
|---|---|
| D02644 | KEGG_DRUG |
| C0771221 | UMLSCUI |
| CHEBI:51235 | CHEBI |
| CHEMBL1201328 | ChEMBL_ID |
| CHEMBL2358147 | ChEMBL_ID |
| DB01038 | DRUGBANK_ID |
| 7140 | IUPHAR_LIGAND_ID |
| 2975-34-0 | SECONDARY_CAS_RN |
| 18104 | PUBCHEM_CID |
| 123579002 | SNOMEDCT_US |
| 782144003 | SNOMEDCT_US |
| 1179 | INN_ID |
| CLY16Y8Z7E | UNII |
| 001486 | NDDF |
| 004593 | NDDF |
None